ライフサイエンスコーパス: Fisher

1 Fisher Discriminant Analysis enables multivariate classi

2 Fisher exact and chi(2) tests were used to assess associ

3 Fisher exact and Wilcoxon tests were used for comparison

4 Fisher exact test and multivariate regression were used

5 Fisher exact test was used to analyze the association of

6 Fisher exact test was used to compare the proportion of

7 Fisher exact test was used to examine the relationship b

8 Fisher exact tests and Kaplan-Meier methods were used to

9 Fisher exact tests compared planned adjuvant treatment d

10 Fisher exact, chi(2), and Kruskal-Wallis tests and analy

11 Fisher exact, Pearson chi(2), and Student t tests were a

12 Fisher information analysis showed that component cells

13 Fisher ratios helped to find the 119 analytes that were

14 Fisher showed, assuming many genes of small effect, Mend

15 Fisher's exact and non-parametric Wilcoxon rank-sum test

16 Fisher's exact test examined the effect of diagnosis on

17 Fisher's exact test was used for the primary end point,

18 Fisher's exact test was used to compare the proportion o

19 Fisher's exact test was used to screen for association w

20 Fisher's key insight yielding this quantitative predicti

21 Fisher's linear discriminant analysis method was employe

22 Fisher-ratio (F-ratio) analysis applied to the supervise

23 with response to interferon therapy (P=1.0, Fisher exact test).

24 tly adjacent to a CSF reservoir (P < 0.0001, Fisher's exact test).

25 er mesh-augmented reinforcement (P < 0.0001; Fisher exact test).

26 th the PCS group (1/822 [0.12%]; P = 0.0002, Fisher exact test).

27 ompared with none in the controls (P=0.0005, Fisher exact test).

28 /=1:10 in postimmunization sera (P = 0.0008, Fisher's exact test).

29 ppeared to provide better coverage (p<0.001, Fisher's exact) for Strep than AMK.

30 1% of cases and 0.9% of controls; P = 0.002, Fisher exact test) and glaucoma (14.3% of cases and 7.2%

31 h prior corticosteroid treatment (P = 0.002, Fisher exact test), but not with sclerosing inflammation

32 the aorta and tetralogy of Fallot (P=0.002; Fisher exact test).

33 red to the non-ischemic patients (P = 0.005, Fisher's exact test).

34 subjects and no control subjects (p = 0.005; Fisher exact and permutation tests).

35 more frequent in female recipients (P=0.007, Fisher exact test) and African American recipients (P<0.

36 missense variants was nonreported (P=0.007; Fisher exact probability test).

37 ignificantly associated with pCR (P = 0.007; Fisher exact test).

38 s experiencing progression to PCa (P = .014, Fisher's exact test).

39 higher than those with T2a lesions (P = .02, Fisher exact test) in the alternative staging system.

40 contrasted with absence of disease (P=0.029, Fisher's exact test, two-sided, verified by permutation

41 h 6 of 34 of those with UC >1 year (P = .04, Fisher's exact test).

42 and other-GP bacteria respectively (p<0.05, Fisher's exact), however, CEF appeared to provide better

43 ow positive HPV results (48% vs. 0%; P=0.06, Fisher exact test).

44 s morphologic features (50% vs. 12%; P=0.07, Fisher exact test) compared with tumors showing negative

45 ont than PDACs without dMMR or MSI (P = .08; Fisher exact test).

46 n the fellow eyes only in 3 cases (p = 0.13, Fisher's exact test).

47 Unpaired Student t, chi(2), Fisher exact, and Mann-Whitney U tests were applied to a

48 ivariate analysis was performed with chi(2), Fisher exact, and Student t tests.

49 Results were analyzed using chi(2), Fisher exact, Mann-Whitney U, and Kruskal-Wallis tests.

50 n or stability was assessed by using chi(2), Fisher exact, or Cochran Armitage trend tests.

51 dependent and paired samples t test, chi(2), Fisher exact, or the Wilcoxon-signed rank test.

52 1.7% (59 of 3402) from May to November 2016 (Fisher exact test, P < .001; odds ratio [OR], 57; 95% CI

53 red with secondary groups (11/49 vs 211/230: Fisher's exact test p<0.0001).

54 inge (6.4% [47 of 739] vs 0.5% [12 of 2627]; Fisher exact test, P < .001; OR, 15.1; 95% CI, 7.9-33.4)

55 dence interval, 1.56 to 2.86; P=1.68x10(-6) (Fisher exact test).

56 s, in which aneuploidy was more common (69%; Fisher's exact test, P=0.0033).

57 and milk from a single dairy (odds ratio, 8; Fisher exact test P value = .023).

58 imperfections and misalignments following a Fisher distribution function, in addition to the intrins

59 ifferences in frequency were assessed with a Fisher exact test corrected for multiple comparisons.

60 was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001).

61 In this paper, we develop an Adaptive Fisher's Combination (AFC) method for joint analysis of

62 More precisely, although Fisher's model was able to explain several statistical p

63 Statistical analysis (Fisher's exact test) indicated there was no significant

64 Chi-square analysis, Fisher's exact test, and multivariable logistic regressi

65 Bacterial leakage was analyzed by chi(2) and Fisher exact tests (alpha = 5%).

66 Pearson chi(2) and Fisher tests were used to assess the association between

67 haracteristics were examined with chi(2) and Fisher's exact tests.

68 iled Mann Whitney U exact tests, chi(2), and Fisher's exact tests to analyse the data.

69 ociation analysis using Cochran-Armitage and Fisher's exact statistical tests identified 1364 statist

70 zed using ANOVA, Wilcoxon Rank Sum, chi, and Fisher Exact tests.

71 ameters, Pearson correlation coefficient and Fisher z transformation were used, which were corrected

72 luated using generalized additive models and Fisher exact tests.

73 Odds ratios (ORs) and Fisher exact P values were calculated to assess risk fac

74 lock methods (block size of 15 patients) and Fisher and Yates tables of random permutations.

75 involvement were analyzed using log-rank and Fisher exact tests.

76 s, Mann-Whitney U, Wilcoxon signed rank, and Fisher exact tests.

77 calculated by using logistic regression and Fisher test, respectively.

78 chi2 Statistics and Fisher exact tests were used to evaluate differences in

79 ), Bland-Altman plot, kappa statistics, and Fisher's exact test were used to assess intra- and inter

80 Wilcoxon rank-sum and Fisher exact tests were performed.

81 methods such as Pearson chi-square test and Fisher Exact test are single test methods and do not wor

82 Groups were compared by using t test and Fisher exact test with a Bonferroni correction applied f

83 performed with Wilcoxon's rank sum test and Fisher's exact test.

84 ficity with that of the permutation test and Fisher's G-test through extensive simulations and by app

85 skal-Wallis H test, Mann-Whitney U test, and Fisher exact test were used to compare the groups, with

86 ruskal-Wallis test, Mann-Whitney U test, and Fisher exact test were used to look for statistically si

87 signed rank tests, Mann-Whitney U tests, and Fisher exact tests.

88 ng Wilcoxon signed-rank, Mann-Whitney U, and Fisher exact tests.

89 n-Whitney tests for continuous variables and Fisher exact tests for categorical data.

90 a were analyzed via analysis of variance and Fisher's post hoc analyses.

91 ences across tumor types (Kruskal-Wallis and Fisher tests), (c) pairwise tests between tumor types (M

92 k versus classical meta-analysis approaches (Fisher's, Stouffer's and the additive method) as well as

93 rimental arm vs 92 (58%) in the control arm (Fisher exact test, P = .66).

94 developed, including classical ones such as Fisher's combined probability test and Stouffer's Z-test

95 describe the motion of cell fronts, such as Fisher's equation, invoke a mean-field assumption which

96 ted versions of classical procedures such as Fisher's method and Stouffer's method where the weight f

97 The software performs a tile-based Fisher ratio (F-ratio) analysis and facilitates a superv

98 roup (P = 0.026), or SFN group (P = 0.002 by Fisher exact test).

99 d in 0.7% and 0.1%, respectively (P=0.002 by Fisher's exact test).

100 ters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test).

101 ver-operating-characteristic analyses and by Fisher exact test for 2 x 2 contingency tables.

102 olecular subtype ( P = .383), as assessed by Fisher's exact test.

103 Two-way analyses of variance, followed by Fisher's protected least significant difference tests (a

104 Its most popular formulation, introduced by Fisher et al., uses n samples to predict the number U of

105 with the classical theory of pulled waves by Fisher and Skellam, suitably adapted to our experimental

106 portions and means were compared using chi2, Fisher exact test, or t test as appropriate.

107 tic independence assumption of the classical Fisher combination test and is computationally efficient

108 The GEE and the classical Fisher combination test, on the other hand, do not contr

109 d Simes procedure (TATES), and the classical Fisher combination test.

110 ostics, Cypress, CA), Elitech MGB Alert CMV (Fisher Scientific, Hanover Park, IL), and Abbott CMV (Ab

111 a novel statistical test employing conjugate Fisher transformations of correlation coefficients, MAGI

112 ymptom reported with loss of asthma control (Fisher exact test; P = .003); overweight/obese children

113 ar groups, respectively (IPV versus control: Fisher's exact test P < 0.001).

114 aureus colonizing AE cases versus controls (Fisher exact test, P = 0.03).

115 rols (5/393 cases versus 32/65,046 controls; Fisher's exact test P = 2.83 x 10(-6), odds ratio = 26.2

116 Here, we use a system of coupled Fisher-Kolmogorov-Petrovsky-Piskunov (F-KPP) equations t

117 elevated baseline peripheral levels of CRP (Fisher's z=0.10, 95% confidence interval (CI)=0.05-0.14)

118 In a Perspective, Mack Su and David Fisher discuss the development of immunotherapies for tr

119 Brain-dead Fisher rats were treated for 6 hours with either saline

120 ocation) or the DNA-binding forkhead domain (Fisher exact test, P = 0.021).

121 on in idiopathic focal childhood epilepsies (Fisher's exact test P = 2.1 x 10(-4)).

122 To tackle the 2-variant case, we exploit Fisher's angular transformation, which despite being dis

123 The evolutionary dynamics follow Fisher's Fundamental Theorem of Natural Selection and a

124 ontext, and propose a framework derived from Fisher information that allows the quantification of inf

125 Furthermore, Fisher information provided explicit spatial information

126 n to zero of 18,055 autosomal and PAR genes (Fisher's exact P < 0.0001).

127 nt compared with 38% in the wait-list group (Fisher's exact test, P=0.01).

128 d using hierarchical cluster analysis (HCA), Fisher-ratio (F-ratio), interval partial least-squares (

129 superior effect of SHUTi versus HealthWatch (Fisher's exact test=0.52; p=0.32).

130 y of GCH1 variants was significantly higher (Fisher's exact test P-value 0.0001) in cases (10/1318 =

131 Linear mixed models with a post hoc Fisher least significant difference test were used to as

132 In Fisher 344 rats, VWR increased eNOS, all SOD isoforms an

133 s understanding to Wright, and formalized in Fisher's infinitesimal model.

134 We tested this hypothesis in Fisher 344 rats, C57BL/6 J wild type and Nox2-/- mice, a

135 value-based meta-analysis methods, including Fisher's, Stouffer's, minP and maxP, is that they are se

136 lass of phenotypic fitness models (including Fisher's model) to 26 empirical landscapes representing

137 4 versus group 1) and the response to IVIG (Fisher's exact P value 4.518x10(-)(03) and 8.224x10(-)(1

138 properties, but its quantification with Karl Fisher titration or thermal gravimetric analysis is prob

139 rain death was induced in 64 ventilated male Fisher rats by inflating a 4.0F Fogarty catheter in the

140 ong patients with type II diabetes mellitus (Fisher's exact test, p = 0.035).

141 with the powers of TATES, Tippett's method, Fisher's combination test, MANOVA, MultiPhen, and SUMSCO

142 o commonly used gene set enrichment methods, Fisher's exact test and the binomial test implemented in

143 irwise LD was estimated using three methods: Fisher's exact test, index of association (IA) and Hedri

144 BS (18 demyelinating, 8 axonal, and 1 Miller Fisher syndrome), 5 had encephalitis (3 with concomitant

145 Once esteemed by William Osler and C. Miller Fisher, these reports are now considered anachronistic.

146 o facilitates differentiation between Miller-Fisher Syndrome (MFS) and BBE in cases of diagnostic dou

147 overlap with our prediction; and a modified Fisher Exact test was implemented to measure how well ou

148 After adjusting for modified Fisher scale, rebleeding, global cerebral oedema, intrac

149 y and growth, a well-known characteristic of Fisher's equation.

150 tion, we develop new, compact expressions of Fisher information-derived measures that bound the robus

151 daptation of Brown's method (an extension of Fisher's method) for combining dependent P-values which

152 We justify the imperfectness of Fisher's model in the simulation study and its applicati

153 chizophrenia based on a threshold version of Fisher's theory.

154 12-week-old Fisher 344 rats were ovariectomized 2 weeks before fligh

155 four categories of theoretical models, only Fisher's geometrical model (FGM) is consistent with our

156 onal oxygen therapy (COT) or HFNC (Optiflow, Fisher & Paykel, New Zealand) supportive therapy accordi

157 the measurement scheme to attain the optimal Fisher information.

158 e characteristics were compared by chi(2) or Fisher exact test (categorical variables) or Wilcoxon ra

159 d for quantitative parameters, the chi(2) or Fisher exact test was used for qualitative parameters, a

160 and those who did not by using the chi(2) or Fisher exact test, as appropriate.

161 rial phases, was compared with the chi(2) or Fisher exact test, as appropriate.

162 ases and genitourinary cases using chi(2) or Fisher exact test, Mann-Whitney test, and logistic regre

163 by using hierarchic regressions or chi(2) or Fisher exact tests and with repeated-measures analysis o

164 Cohen kappa, Mann-Whitney U, chi(2) or Fisher exact, Kruskal-Wallis, and Spearman statistics we

165 using the Mann-Whitney-Wilcoxon, chi(2), or Fisher exact test.

166 PO was compared with the chi(2) statistic or Fisher exact test, and multivariate analysis was perform

167 ontinuous variables and Pearson chi2 test or Fisher exact test for categorical variables.

168 McNemar's test or Fisher exact test was used to compare proportions.

169 The chi(2) test or Fisher exact test were used, as appropriate, for categor

170 s were analyzed with Pearson chi(2) tests or Fisher exact tests, while continuous variables were anal

171 used for continuous variables and t-tests or Fisher's exact tests were used to compare treatment grou

172 e Empirical Brown's method (EBM) outperforms Fisher's method as well as alternative approaches for co

173 alence of each incidental finding, performed Fisher exact test or chi-square test for categorical var

174 acid or N-glycosylation motif, and performs Fisher's exact test to detect potential positive or nega

175 Two-way analysis of variance and posterior Fisher least significant difference test were used to ob

176 mental limit of T(2) time scaling of quantum Fisher information can be broken with time-dependent Ham

177 We obtain the optimal quantum Fisher information for parameters in time-dependent Hami

178 By computing the quantum Fisher information we determine how relativistic motion

179 he motion-induced degradation of the quantum Fisher information.

180 We show, using quantum Fisher information, that the precision of our technique

181 in men and women (51% and 54%, respectively; Fisher exact test =0.39; equivalence P=0.0002).

182 on, which despite being discovered by Ronald Fisher a century ago, has remained an intellectual curio

183 the past 3 days on the numeric rating scale (Fisher exact test, P = 0.0026), Patient-Oriented Eczema

184 and Neisseria lactamica (P < 0.002) (2-sided Fisher's exact test) was more likely in the smaller, mor

185 Two-sided Fisher exact and paired t tests were used for categorica

186 t week 4 (38% vs. 13%, P=0.04 by a two-sided Fisher's exact test in the A5340 trial; and 80% vs. 13%,

187 ial; and 80% vs. 13%, P<0.001 by a two-sided Fisher's exact test in the NIH trial) but the difference

188 centre of modern evolutionary biology since Fisher; however, evaluating how the genetic architecture

189 model's predictors were age, aneurysm size, Fisher grade, and World Federation of Neurological Surge

190 Standardized Fisher transformations of the correlations between corti

191 A 2-tailed Fisher exact test and paired Student t test were used fo

192 A 2-tailed Fisher exact test was the statistical method used.

193 A 2-tailed Fisher exact test was used to assess for differences in

194 ined analysis (p = 2.68 x 10(-4), two-tailed Fisher's exact test), indicating that the SLC2A3 duplica

195 bject without (p = 3.12 x 10(-3), two-tailed Fisher's exact test).

196 cts with CHDs (p = 3.30 x 10(-2), two-tailed Fisher's exact test).

197 ive for enterovirus D68 using the two-tailed Fisher's exact test, two-sample unpaired t test, and Man

198 al rate-comparison methods, e.g. chi 2 test, Fisher's exact test and Binomial test.

199 d the independent samples t test, x(2) test, Fisher exact test, and Cohen k.

200 chi(2) test, Fisher exact test, and Mann-Whitney U test were used to

201 For statistical analysis, chi(2) test, Fisher exact test, Mann-Whitney U test, and Wilcoxon tes

202 by using descriptive statistic, chi(2) test, Fisher exact test, t test, and repeated-measures analysi

203 groups were performed with chi-square test, Fisher exact test, and t tests.

204 s of the thorax by using the Student t test, Fisher exact test, and Pearson correlation.

205 lysis included use of the two-sample t test, Fisher exact test, and Spearman correlation.

206 e investigated (ancova, Mann-Whitney U-test, Fisher exact test).

207 For statistic analyses Mann-Whitney U-test, Fisher's exact test and binary logistic regression were

208 e logistic regression, Welch t test, Z test, Fisher-exact test, Shapiro-Wilk test, and receiver opera

209 The Fisher exact and Wilcoxon rank sum tests were used to de

210 The Fisher exact test (2-tailed) was used to compare proport

211 The Fisher exact test and exact logistic regression were use

212 The Fisher exact test and Student t test analysis were perfo

213 The Fisher exact test was used to compare proportions; the S

214 The Fisher exact test was used to compare the risks of strok

215 The Fisher exact test was used to compare the two groups.

216 The Fisher exact test was used to determine differences betw

217 The Fisher's geometric model is common in detecting the epis

218 The Fisher-alpha index displayed the higher values for the f

219 ts were used to compare biopsy time, and the Fisher exact test was used to compare lesion type distri

220 analysis using analysis of variance and the Fisher exact test.

221 ver operating characteristic curves, and the Fisher exact test.

222 nhibition increases both the entropy and the Fisher information of the network evoked responses.

223 tions and associated quantities, such as the Fisher Information Matrix and Kullback-Leibler divergenc

224 sed P-value combination methods (such as the Fisher's combined test, the truncated product method, th

225 The statistical analysis, evaluated by the Fisher exact test, did not show a significant postoperat

226 and front propagation speed predicted by the Fisher-Kolmogorov equation.

227 by alleviating interference competition (the Fisher-Muller effect) or by separating them from deleter

228 Because the 1-tailed P value from the Fisher exact test was <.001, which crossed the superiori

229 uses the parameter manifold's geometry (the Fisher information) to make efficient moves.

230 ped shot noise into the variance term in the Fisher matrix yielded fundamental Cramer-Rao lower bound

231 introducing demographic stochasticity in the Fisher-Kolmogorov framework of reaction-diffusion proces

232 DPRP provides three methods: the Fisher's Exact Test, the Kolmogorov-Smirnov test and the

233 del to estimate the null distribution of the Fisher combination test statistic.

234 by using the Freeman-Halton extension of the Fisher exact probability test.

235 lly, models of this process are based on the Fisher-Kolmogorov equation; however, such continuum repr

236 ntrol is generally necessary to optimize the Fisher information.

237 We performed the Fisher exact test for comparison of categorical values a

238 performed using Wilcoxon rank-sum tests, the Fisher exact test, and Kaplan-Meier analysis.

239 orical variables were evaluated by using the Fisher exact test and linear models with generalized est

240 Comparisons were conducted by using the Fisher exact test and log-rank test.

241 esions for association with CPM by using the Fisher exact test, exact chi(2) test, and multivariate l

242 Comparison of proportions was made using the Fisher exact test, using an alpha risk of 0.05 as clinic

243 tegoric variables were compared by using the Fisher exact test.

244 in CE-MARC groups were compared by using the Fisher exact test.

245 mpared in the matched subgroups by using the Fisher exact test.

246 tes were compared across groups by using the Fisher exact test.

247 and compared categorical variables using the Fisher exact test.

248 M5C, and BAP1 genes were tested by using the Fisher exact test.

249 were compared across sequences by using the Fisher exact test.

250 cts and those with sporadic CCM by using the Fisher exact test.

251 erfusion patterns were analyzed by using the Fisher exact test.

252 o enable experimental optimisation using the Fisher Information Matrix it efficiently allows one to c

253 ps between both arms were compared using the Fisher's exact test and Wilcoxon Rank Sum test.

254 ortion of 22q11.2 deletions found, using the Fisher's exact test for the independent case-control stu

255 Associations were tested with the Fisher exact test.

256 categorical variables were compared with the Fisher exact test.

257 nd clinical management was assessed with the Fisher exact test.

258 y sensitive, both the Agena panel and Thermo Fisher NGS fusion panel reported minor fusions that were

259 limitations of ImmunoCAP IgE assays (Thermo Fisher Scientific/Phadia, Uppsala, Sweden) in the field

260 he proprietary RAW files generated by Thermo Fisher mass spectrometers is the primary step for subseq

261 rap mass spectrometer (LTQ-Velos Pro, Thermo Fisher) for resolving complex mixtures of natural aquati

262 ter (IRIS) (in this case a Delta Ray (Thermo Fisher Scientific)).

263 ion on RAW files from high-resolution Thermo Fisher mass spectrometers.

264 oth microdilution device (Sensititre; Thermo Fisher Scientific) was validated using 285 selected Gram

265 itrap Elite hybrid mass spectrometer (Thermo Fisher Scientific, CA, USA) at resolving power settings

266 ution LC/mass spectrometry (LC-UHRMS; Thermo Fisher Q-Exactive) was used to identify two novel isomer

267 modifier genes that activate transcription (Fisher exact p = 0.0004, permutations, p = 0.0003, OR =

268 analysed using Chi-square test or Univariate Fisher's exact test.

269 We use Fisher information, an information theory-based method,

270 ished association methods: the commonly used Fisher's method for combining P-values and also the rece

271 We used Fisher's exact test to compare unadjusted attack rates a

272 aphic method of estimating Ne /N, which uses Fisher's reproductive value to account for dynamic age-s

273 The results were analyzed using Fisher exact tests and multivariable logistic regression

274 Comparisons of regimens were assessed using Fisher exact test.

275 l characteristics and perceived burden using Fisher's exact test and bivariate modified Poisson regre

276 th pathologic findings and compared by using Fisher exact or t test, with a Bonferroni correction for

277 th these mutations was investigated by using Fisher test.

278 Haplotype frequencies were compared using Fisher's exact test.

279 2 groups were calculated and compared using Fisher's test.

280 ombined data from the three electrodes using Fisher's method so that each participant was assigned a

281 study entry VL, and CD4 were evaluated using Fisher exact and Kruskall-Wallis tests.

282 nth posttransplant 6MWD were evaluated using Fisher exact test and Spearman correlation.

283 n both terrestrial and aquatic systems using Fisher information.

284 Mann-Whitney, Fisher exact, and Wilcoxon matched-pair signed rank test

285 rates across cancer type were compared with Fisher's exact and log-rank tests, respectively.

286 nia is largely polygenic, and congruent with Fisher's and Gottesman's models.

287 Categorical data were evaluated with Fisher's exact test.

288 d occluded vessels for each vessel type with Fisher exact test.

289 We also combined the resulting P values with Fisher's method to estimate the association between sodi

290 lcification (44% of men versus 48% of women; Fisher exact test P=0.56; equivalence P=0.041).

291 process, as well as for the (haploid) Wright Fisher model are presented.

292 ly, our framework also incorporates a Wright-Fisher genealogical model of hosts, so that the dynamics

293 rom that predicted from the classical Wright-Fisher (WF) model, which assumes a single random-mating

294 ns of the Moran model and the haploid Wright-Fisher model) to examine fixation probabilities for a co

295 ese issues, we developed a multilocus Wright-Fisher model of HIV dynamics with selection, mutation an

296 In the Wright-Fisher diffusion, the transition density function descri

297 population genetic models such as the Wright-Fisher model and the Kingman coalescent that do not adeq

298 m a population under selection in the Wright-Fisher model of evolutionary dynamics.

299 xact computation in the discrete-time Wright-Fisher (DTWF) model and compare several key genealogical

300 te approximation of the discrete time Wright-Fisher model (DTWF).